0.24% +0.010

Adc Therapeutics SA (ADCT)

Adc Therapeutics SA Borsa (ADCT) Ultime notizie

Adc Therapeutics SA (ADCT)

Adc Therapeutics SA Borsa (ADCT) Ultime notizie

A look into Adc Therapeutics SA (ADCT)'s deeper side – Sete News - SETE News

ADC Therapeutics SA's $105 Million Common Shares Offering – Global Legal Chronicle - Global Legal Chronicle

ADC Therapeutics wird an der H.C. Wainwright 2nd Annual BioConnect Investor Conference an der NASDAQ teilnehmen

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Singapore News

The Adc Therapeutics SA (ADCT) had a good session last reading, didn't it? – US Post News - US Post News

Financial Metrics Exploration: Understanding Adc Therapeutics SA (ADCT) Through Ratios – DWinneX - The Dwinnex

ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewswire

ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

ADC Therapeutics Unveils Strategic Insights in New Presentation - TipRanks.com - TipRanks

ADC Therapeutics down 7% following new corporate presentation - Seeking Alpha

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo News UK

ADC Therapeutics SA (ADCT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Movies UK

ADC Therapeutics SA (ADCT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Movies UK

Financial Comparison: ADC Therapeutics (NYSE:ADCT) vs. Acasti Pharma (NASDAQ:ACST) - Defense World

Redmile Group acquires $69.1 million in ADC Therapeutics pre-funded warrants - Investing.com

Public equity report: iTeos, ADC Therapeutics, Eledon draw fundings - BioCentury

Analysts Are Updating Their ADC Therapeutics SA (NYSE:ADCT) Estimates After Its First-Quarter Results - Simply Wall St

ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference - Informazione.it

Adc therapeutics CEO sells shares worth over $133k - Investing.com

ADC Therapeutics nimmt an der RBC Capital Markets Global Healthcare Conference 2024 teil

ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference

ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

Insider Selling: ADC Therapeutics SA (NYSE:ADCT) CEO Sells 29,731 Shares of Stock - MarketBeat

ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations - Simply Wall St

ADC Therapeutics (NYSE:ADCT) Price Target Cut to $8.00 by Analysts at HC Wainwright - Defense World

ADC Therapeutics veröffentlicht die Finanzergebnisse des ersten Quartals 2024 und gibt aktuelle Informationen zum Geschäftsverlauf bekannt

GB01-VA-PL2202, a Claudin-6-targeting ADC with potent antitumor efficacy and bystander killing activity - BioWorld Online

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript - Insider Monkey

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript - Insider Monkey

ADC Therapeutics kündigt garantiertes Angebot an Stammaktien und Pre-Funded Warrants im Umfang von USD 105 Mio. an

ADC Therapeutics gibt erste Daten der von einem Prüfarzt initiierten klinischen Phase-II-Studie mit ZYNLONTA® bei Patienten mit rezidiviertem/refraktärem Marginalzonen-Lymphom bekannt

ZYNLONTA shows high response rate in lymphoma trial - Investing.com South Africa

ZYNLONTA shows high response rate in lymphoma trial - Investing.com

ADC Therapeutics announces $105 million shares offering - Investing.com India

ADC Therapeutics announces $105 million shares offering By Investing.com - Investing.com

ADC Therapeutics stock jumps on earnings beat By Investing.com - Investing.com Nigeria

ADC Therapeutics SA 2024 Q1 - Results - Earnings Call Presentation (NYSE:ADCT) - Seeking Alpha

ADC Therapeutics : 1Q 2024 Earnings Call - Marketscreener.com

ADC Therapeutics stock jumps on earnings beat - Investing.com India

ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants - GlobeNewswire

ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

ADC Therapeutics SA Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com

ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients ... - Marketscreener.com

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients ... - Marketscreener.com

After Plunging -34.06% in 4 Weeks, Here's Why the Trend Might Reverse for ADC Therapeutics SA (ADCT) - Yahoo Singapore News

ADC Therapeutics (ADCT) Set to Announce Quarterly Earnings on Monday - Defense World

ADC Therapeutics (ADCT) Set to Announce Quarterly Earnings on Monday - Defense World

Loss-Making ADC Therapeutics SA (NYSE:ADCT) Expected To Breakeven In The Medium-Term - Yahoo Movies UK

Simile a ADCT